All lobbying filings
SL STRATEGIES, LLC
SL STRATEGIES, LLC filed a Q2 report for ARGENTUM MEDICAL DBA BRAVIDA MEDICAL on August 17, 2026, reporting $40,000 in lobbying income.
Lobbying for ARGENTUM MEDICAL DBA BRAVIDA MEDICAL · leading manufacturer of antimicrobial solutions with an emphasis on hospital and surgery
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Aug 17, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
Illinois
Lobbyists on this filing
1
-
MARY MOODY JOHNSON New on this filingPreviously held: U.S. Senate Committee on Health, Education, Labor and Pensions
Government bodies contacted
3
Lobbying activity
3
Fiscal year 2027 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile and Department of Defense.
Policies impacting rad/nuc preparedness and response
Policies impacting prepositioning of rad/nuc countermeasures.